secwatch.observer — SEC 8-K summary
======================================

Issuer:     Immunome Inc. (IMNM)
CIK:        0001472012
Form:       8-K
Filed at:   2023-01-30T23:59:59+00:00
Accession:  0001104659-23-007738
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Immunome posts corporate presentation on website for investor meetings
----------------------------------------------------------------------

- Posted presentation dated January 2023 under Item 8.01 of Form 8-K.
- Presentation may be used in meetings with investors, analysts, collaborators, vendors.
- Presentation attached as Exhibit 99.1 and incorporated by reference into Item 8.01.
- Report signed by President and CEO Purnanand D. Sarma on January 30, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1472012/000110465923007738/0001104659-23-007738-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1472012/000110465923007738/tm234730d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-007738

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer